SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: John Metcalf who wrote (645)3/3/1999 1:44:00 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 1073
 
John:

This PIII DHEA trial was *phisician sponsored *, mainly designed in Canada. Bottom line is that there was very little expense for NBIX and with *small* marketing potential (drug should be marketed in Canada and EU because DEHA is OTC drug in US.

AHP deal is interesting one.

Miljenko